Related Experiment Video

Updated: Aug 8, 2026

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
08:10

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

Topical application of integrin antagonists inhibits proliferative retinopathy

B Riecke1, E Chavakis, R G Bretzel

  • 13rd Medical Department, Justus-Liebig-University Giessen, Germany.

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|July 7, 2001
PubMed

Insights

Topical cyclic RGD peptides effectively inhibit proliferative retinopathy by targeting alphav-integrins. This approach minimizes side effects compared to systemic treatments for retinopathy of prematurity.

Area of Science:

  • Ophthalmology
  • Vascular Biology
  • Pharmacology

Background:

  • Alphav-integrins are crucial for angiogenic endothelial cells.
  • Cyclic RGD peptides inhibit pathological neovascularization.
  • Previous studies showed >70% reduction in retinopathy of prematurity (ROP) with systemic RGD peptides.

Purpose of the Study:

  • To investigate the efficacy of topical application of cyclic RGD peptides for inhibiting proliferative retinopathy.
  • To minimize systemic side effects and interference with normal angiogenesis.

Main Methods:

  • Topical application of cyclic RGD peptides in a mouse model of ROP.
  • Confirmation of retinal presence of RGD peptides using fluorescein labeling.
  • Dose-response analysis of topical peptide application.

Main Results:

  • Topical application confirmed retinal presence of RGD peptides.
  • Inhibition of proliferative retinopathy was observed in a dose-dependent manner.
  • A maximum inhibition of nearly 50% was achieved with topical application.

Conclusions:

  • Topical cyclic RGD peptides are effective in inhibiting proliferative retinopathy.
  • This localized delivery minimizes systemic exposure and side effects.
  • Small molecule alphav-integrin antagonists show promise for topical ROP treatment.

More Related Videos

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases06:51

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

Published on: December 9, 2022

Related Concept Videos

Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...